CairnSurgical
CairnSurgical
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.CairnSurgical is developing the Breast Cancer Locator™ System to improve breast-conserving surgery by enhancing tumor localization and tissue inspection.
About
CairnSurgical is a medical device startup focused on improving outcomes in breast-conserving surgery. Their flagship product, the Breast Cancer Locator™ System, is a patient-specific image guidance tool designed to precisely localize tumors and facilitate thorough tissue inspection, aiming to reduce the high rates of re-excision currently experienced by patients.
Key facts
At-a-glance profile data
- Website
- cairnsurgical.com
- Headquarters
- Boston, United States
- Founded
- 2015
- Total funding
- $23M (Series A2)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Aug 2024 | Series A2 | $5M | Morningside Ventures |
| 1 Oct 2023 | Series A3 | $10M | - |
| 1 Jan 2020 | Seed | $1M | - |
| 17 Dec 2019 | Series A | $5M | Morningside Group |
| 12 Sept 2018 | Grant | $2M | - |
Tech stack
Detected on cairnsurgical.com, last scanned 25 Sept 2026. Run your own scan
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has CairnSurgical raised?
CairnSurgical has raised a total of $23M in funding. The most recent round on record is Series A2.